Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.20.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Accounts receivable allowance $ 230,000 $ 0
Inventory allowance 2,000
Net of amortization, Right-of-use assets 349,000
Property and equipment, net of accumulated depreciation 164,000 97,000
Intangible assets, net of amortization 975,000
Accrued interest, related parties 82,000 41,000
Net of discount in future receipts 274,000
Convertible notes payable, discount $ 0 $ 1,082,000
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 15,000,000 15,000,000
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 200,000,000 200,000,000
Common stock, shares issued 24,496,197 12,055,491
Common stock, shares outstanding 24,496,197 12,055,491
Series A Convertible Preferred Stock [Member]    
Preferred stock, shares authorized 6,000 6,000
Preferred stock, shares issued 4,396 0
Preferred stock, shares outstanding 4,396 0